Phase I Combination w/ Epirubicin

Clinical trial NCT00322374 · COMPLETED

Trial details

NCT number: NCT00322374
Sponsor: R-Pharm
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2006-08-01
Primary completion: 2009-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.